Winton Capital »

Lenz Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $332k 7.1k 46.58

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ge Vernova (GEV)
Select Sector Spdr Tr Sbi Materials (XLB)
Devon Energy Corporation (DVN)
Interactive Brokers Group In Com Cl A (IBKR)
Meta Platforms Cl A (META)
Uber Technologies (UBER)
Fastenal Company (FAST)
Incyte Corporation (INCY)
Masco Corporation (MAS)
Five Below (FIVE)
Johnson Ctls Intl SHS (JCI)

View all positions for Winton Capital

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Morgan Stanley
Geode Capital Management

View all funds holding Lenz Therapeutics